Collaborative IP strategies for publicly funded R&D needed now and for the future

There is little doubt that IP, especially patents, should not be an impediment to forging solutions to the global crisis that we are all facing. It is important that Canada’s policy-makers continue to explore models for facilitating collaborative development and access to essential medicines, treatments, technologies and other innovations.

IP rights have sparked global discourse, especially in the area of patents, because they apply to everything from the medications and respirators for those who are sick, to the protective equipment required by health-care workers, to the vaccine(s) which we will all, ultimately, require, write Karima Bawa and Myra Tawfik.Image courtesy of Pixabay

Opinion

BY KARIMA BAWA AND MYRA TAWFIK

September 14, 2020

It has been said that a crisis brings out the best and the worst in people. This pandemic is no different. So many people and so many nations have come together in hopes of finding solutions more quickly by sharing and pooling their resources. They have clearly put the collective good ahead of their...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy